Monthly Archives: January 2012

Pharma: Get Ready for the New Supply Chains

New pharma supply chains, where chill control and traceability challenges will be far more critical, will emerge over the next decade, So it’s time, argues Julian Mosquera, for the industry to upgrade its capabilities. The pharmaceuticals industry is undergoing major disruption and every comparative benchmark indicates that the sector needs to make a step change […]
Posted in Global, Guest Blog, Safety, Supply Chain | Tagged , , | 1 Comment

Sales Rep vs. eDetail: Consider the Practice Area

Forget illegal immigrants, it is machines that are stealing American jobs. For some medical practice areas, however, digital details haven’t sufficiently stepped in where their human sales rep predecessors have stepped (or have been pushed) out, according to a survey of U.S. physicians.
Posted in Advertising, E-Media, Marketing, Sales, Strategy | Tagged , , | 2 Comments

Genentech Runs Voluntary Corrective Ads for Boniva

Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.
Posted in Advertising, compliance, Corporate Responsibility, FDA, leadership, Legal, Marketing, Regulatory | Tagged , , , | Leave a comment

Close to Home: Is Good Health Communicable?

The 2011 Edelman Health Barometer suggests that—in the same way that we spread colds, diseases, and other illnesses from person to person—good health and healthy behaviors can also be spread. Can pharma play a pivotal role in the good-health epidemic? Energy. An active lifestyle. Mental and emotional stability. Absence of disease. Nutrition. These are some […]
Posted in healthcare, social media, Technology | Tagged , , , | 1 Comment

JP Morgan Healthcare Conference Marked by Uncertainty

2012 J.P. Morgan Healthcare Conference Marked by Uncertainty Audrey S. Erbes, Principal, Erbes & Associates, outlines the highlights of this week’s event in San Francisco. One of the few positive notes struck in this week’s 30th Annual J.P. Morgan Healthcare Conference (held in San Francisco) was the announcement by Kevin Willsey, J.P. Morgan’s co-head of […]
Posted in Guest Blog, healthcare, R&D, Strategy | Tagged , , , , | 2 Comments
  • Categories

  • Meta